OTC Ad Study May Overstate “Misleading” Claims – Ex-FTC Attorneys
This article was originally published in The Tan Sheet
Executive Summary
An analysis of TV ads found more ads for OTC drugs than Rx drugs contain false claims, while both classes feature prevalent “potentially misleading” claims. Former FTC attorney C. Lee Peeler disagrees with how the researchers classify misleading claims.